A Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of an investigational compound to be combined with MasterGraftTM Matrix in Subjects Undergoing Lumbar Interbody Fusion with Instrumentation via a Posterior Approach.

Requirements:

·          Male or Female (Females can not be pregnant or breastfeeding.

·          18 to 70 years of age

·          Diagnosed with degenerative disc disease (DDD)

o        in 1 or 2 adjacent vertebral levels between L1 and S1

o        with or without spinal stenosis and

o        with or without Grade II degenerative spondylolisthesis or spinal stenosis.

·          Subjects must have clinical symptoms of DDD and have failed 6 months of non-operative management.

If you would like to learn more about this study please contact Crystal Hill at (919) 281-1870 or by email at chill@triangleortho.com